Women's Health Market To Experience Lucrative Growth Due To Favorable Government Policies & Initiatives By Private Organizations Till 2025: Grand View Research, Inc.
The
global women’s health market is expected to reach USD
51.3 billion by 2025, according to a new report by Grand View Research, Inc.
Increasing female geriatric population, introduction of various drugs related
to women’s health, and favorable government policies are some of the factors
expected to drive growth during the forecast period.
Women
are more prone to certain diseases, such as osteoporosis, osteoarthritis,
anemia, menstruation-related disorders, depression, and obesity. Hence,
increase in incidence of these conditions is likely to boost the market in the
coming years. According to International Osteoporosis Foundation, global
prevalence of osteoporosis among women was over 200.0 million in 1990, and this
is anticipated to reach 680.0 million in 2050.
Government
and various private organizations are working toward improving women’s health
across the world, and this is likely to drive growth in the coming years.
Reimbursement coverage provided to women is also a key factor driving the
market in developed countries. For instance, various coverage plans in the U.S.
provide preventive services for women without charging any copayment. These
include screening for anemia, hepatitis B, & breast cancer on a routine
basis, folic acid supplements for women who are likely to be pregnant, and
contraceptive methods, among others.
U.S.
women’s health market by application, 2014 - 2025 (USD Billion)
Browse full research report on Women's
Health Market: http://www.grandviewresearch.com/industry-analysis/womens-health-market
Further
Key Findings From the Study Suggest:
- Presence of a large female geriatric
population, which is susceptible to chronic diseases, is expected to boost
growth
- In 2016, postmenopausal osteoporosis accounted
for the largest share of the market due to high incidence of osteoporosis
in women after menopause, presence of several major players, and
cost-effectiveness of this treatment
- Contraceptive segment is likely to witness
fastest growth during the forecast period due to increase in awareness and
usage, government initiatives, technological developments, and favorable
regulatory scenario. For instance, in June 2017, Agile Therapeutics, Inc.
resubmitted an NDA for Twirla, an investigational low-dose combined
hormonal contraceptive patch
- Geographically, North America held the largest
share of more than 30% in 2016 due to presence of major market players,
high awareness about regular health check-ups for women, coverage for
screening, and increased healthcare expenditure
- Asia Pacific is expected to exhibit fastest
growth during the forecast period due to increasing investments by players
in the region, rising awareness about women’s health, and initiatives by
various governments and private organizations to improve awareness and
access to women’s health products
- Some of the key players operating in the
women’s health market are Allergan; Bayer AG; Merck & Co., Inc.;
Pfizer, Inc.; Teva Pharmaceutical Industries Ltd.; Agile Therapeutics;
Amgen, Inc.; AstraZeneca; Bristol-Myers Squibb Company; and Ferring B.V.
Access
Press Release By Grand View Research: http://www.grandviewresearch.com/press-release/global-womens-health-market
About
Grand View Research, Inc:
Grand View Research, Inc. is a U.S. based market
research and consulting company, registered in the State of California and
headquartered in San Francisco. The company provides syndicated research
reports, customized research reports, and consulting services. To help clients
make informed business decisions, the company offers market intelligence
studies ensuring relevant and fact-based research across a range of industries
including technology, chemicals, materials, healthcare and energy.
Comments
Post a Comment